• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Intermagnetics reports strong growth

Article

Intermagnetics General continued an upward financial ride throughthe first half of fiscal 1996. The Latham, NY, maker of superconducting magnets, wire andfreon-replacement refrigerants reported second-quarter revenuesof $23.7 million, up 18% from the

Intermagnetics General continued an upward financial ride throughthe first half of fiscal 1996.

The Latham, NY, maker of superconducting magnets, wire andfreon-replacement refrigerants reported second-quarter revenuesof $23.7 million, up 18% from the second quarter of fiscal 1995.Sales of $45 million for the first half of the fiscal year wereup 25% from the year before.

Quarterly net income of $1.1 million was 36% higher than second-quarter1994 results. Through the first half of fiscal 1995, earningsincreased 72% to $1.8 million.

Intermagnetics' earnings improved despite a 24% decline insecond-quarter margins, according to CEO Carl Rosner. He blamedthe downturn on magnet and wire price reductions, lower wire productionyields, a change in sales mix, and substantial rework costs forcryogenic products.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.